Publications by authors named "Anne Monks"

Claim this Profile
C
Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer.
Mathias Dahlmann, Anne Monks, Erik D Harris, Dennis Kobelt, Marc Osterland

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATR inhibition reverses the resistance of homologous recombination deficient MGMT/MMR cancer cells to temozolomide.
Lara H El Touny, Curtis Hose, John Connelly, Erik Harris, Anne Monks

Oncotarget· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines.
Dong-Joon Min, Yingdong Zhao, Anne Monks, Alida Palmisano, Curtis Hose

Cancer Chemother Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel.
Anne Monks, Yingdong Zhao, Curtis Hose, Hossein Hamed, Julia Krushkal

Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Transcriptional Response of Glycosylation-Related Genes, Regulators, and Targets in Cancer Cell Lines Treated With 11 Antitumor Agents.
Julia Krushkal, Yingdong Zhao, Curtis Hose, Anne Monks, James H Doroshow

Cancer Inform· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases.
Jiamo Lu, Prabhakar Risbood, Charles T Kane, Md Tafazzal Hossain, Larry Anderson, Anne Monks

Biochem Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment.
Julia Krushkal, Yingdong Zhao, Curtis Hose, Anne Monks, James H Doroshow

Clin Epigenetics· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.
Eric Polley, Mark Kunkel, David Evans, Thomas Silvers, Rene Delosh, Anne Monks

J Natl Cancer Inst· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
Sameer H Issaq, Beverly A Teicher, Anne Monks

Cell Cycle· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bromodomain and hedgehog pathway targets in small cell lung cancer.
Gurmeet Kaur, Russell A Reinhart, Anne Monks, David Evans, Joel Morris

Cancer Lett· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression.
Beverly A Teicher, Eric Polley, Mark Kunkel, David Evans, Thomas Silvers, Anne Monks

Mol Cancer Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery.
Erica L Stone, Francesca Citossi, Rajinder Singh, Balvinder Kaur, Margaret Gaskell, Anne Monks

Bioorg Med Chem· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small molecule (pluripotin) as a tool for studying cancer stem cell biology: proof of concept.
Susan D Mertins, Dominic A Scudiero, Melinda G Hollingshead, Raymond D Divelbiss, Michael C Alley, Anne Monks

PLoS One· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cediranib for metastatic alveolar soft part sarcoma.
Shivaani Kummar, Deborah Allen, Anne Monks, Eric C Polley, Curtis D Hose

J Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma.
Vaibhav Saini, Curtis D Hose, Anne Monks, Kunio Nagashima, Bingnan Han

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaphostin toxicity in a sensitive non-small cell lung cancer model is mediated through Nrf2 signaling and heme oxygenase 1.
Nicole D Fer, Robert H Shoemaker, Anne Monks

J Exp Clin Cancer Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of antiproliferative phenylmaleimides that activate the unfolded protein response.
Ulrike Muus, Curtis Hose, Wei Yao, Teresa Kosakowska-Cholody, David Farnsworth, Anne Monks

Bioorg Med Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide].
Andrew G Jobson, George T Lountos, Philip L Lorenzi, Jenny Llamas, John Connelly, Anne Monks

J Pharmacol Exp Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts.
Anne Monks, Curtis D Hose, Patrick Pezzoli, Sudhir Kondapaka, Gordon Vansant

Anticancer Drugs· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies.
Shivaani Kummar, Robert Kinders, Martin E Gutierrez, Larry Rubinstein, Ralph E Parchment, Anne Monks

J Clin Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth inhibition of hepatocellular carcinoma cells in vitro and in vivo by the 8-methoxy analog of WMC79.
Teresa Kosakowska-Cholody, Wieslaw M Cholody, Humcha K Hariprakasha, Anne Monks, Siddhartha Kar

Cancer Chemother Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth.
Jeanelle M Martinez, Tina Sali, Ryuji Okazaki, Colleen Anna, Melinda Hollingshead, Anne Monks

J Pharmacol Exp Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential gene expression as a potential classifier of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole-sensitive and -insensitive cell lines.
Anders Wallqvist, John Connelly, Edward A Sausville, David G Covell, Anne Monks

Mol Pharmacol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
Dehe Kong, Eun Jung Park, Andrew G Stephen, Maura Calvani, John H Cardellina, Anne Monks

Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway.
Teresa Kosakowska-Cholody, W Marek Cholody, Anne Monks, Barbara A Woynarowska, Christopher J Michejda

Mol Cancer Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis